☆ 4.7 Letter

Identification of druggable inhibitory immune checkpoints on Natural Killer cells in COVID-19

CELLULAR & MOLECULAR IMMUNOLOGY (2020)

Get Full Text
Add to Collection

Journal

CELLULAR & MOLECULAR IMMUNOLOGY
Volume 17, Issue 9, Pages 995-997

Publisher

CHIN SOCIETY IMMUNOLOGY
DOI: 10.1038/s41423-020-0493-9

Keywords

-

Categories

Immunology

Funding

  1. European Research Council (ERC) under the European Union's Horizon 2020 research and innovation program [694502, 875102-MInflaTilc]
  2. Agence Nationale de la Recherche
  3. PIONEER Project [ANR-17-RHUS-0007]
  4. MSDAvenir
  5. Innate Pharma
  6. CIML (INSERM, CNRS)
  7. CIML (Aix-Marseille University)
  8. Marseille Immunopole

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.